Ticker HubNasdaq

LUNG

Pulmonx Corporation Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUSLatest afterhours mover

Latest price

$2.21+13.22%

As of Oct 27, 2026, 8:00 PM EDT · Market data by Massive

Market cap

$83.7M

Volume

491K

Previous close

$1.95

Day range

$1.92 – $2.03

Listed

Oct 1, 2020

Coverage

0 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $1.82Latest interval $2.21

Newsroom

Latest LUNG coverage

No matching articles yet.

Recent catalyst headlines

Pulmonx Reports Third Quarter 2026 Financial Results

Oct 27, 2026

Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026

Oct 13, 2026

Pulmonx Shares Fall Following Recent Gains

Sep 3, 2026

Company overview

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 296
Headquarters: REDWOOD CITY, CA
CIK: 0001127537

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

Oct 1, 2020

Listed

296

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.